General Archive

  • Melanie Lee, LifeArc CEO
    News releases

    LifeArc monetises Keytruda® royalty interests to fund further research and investment

    LifeArc receives US$1.3bn for a portion of royalty interests in Keytruda (pembrolizumab), making us one of the UK’s leading medical…

    Read more

  • News releases

    Medicines Discovery Catapult and LifeArc launch strategic R&D partnership in biomarker discovery and proteomics technology

    Three-year partnership to fund clinical application of biomarker strategies to help progress novel drug candidates to clinical evaluation stage

    Read more

  • Plate washer in a lab
    News releases

    LifeArc and The University of Kent collaborate to develop potential pain medicines

    Three-year programme will focus on ion channel drug discovery, to evaluate if small molecule modulators, optimised as part of the…

    Read more

  • Composite head shot
    News releases

    LifeArc licenses lead stage molecules to Daiichi Sankyo

    LifeArc, one of the UK’s leading medical research charities, has signed a deal to license an ion channel drug discovery…

    Read more

  • Morphological changes in breast cancer cells
    News releases

    Cancer Research UK, Lifearc and Ono Pharma Form Cancer Immunotherapy Alliance

    New immunotherapy drug targets for cancer will be progressed through a multimillion-pound drug discovery alliance announced today (Wednesday) between Cancer…

    Read more

  • DEBRA Austria picture
    Articles

    Alliance enables clinical trial of experimental treatment for epidermolysis bullosa

    An experimental medicine to treat the rare inherited skin disorder epidermolysis bullosa (EB) is on track to start trials in…

    Read more

  • gala feature 2
    Articles

    Melanie Lee, a life in life sciences

    Melanie Lee, LifeArc CEO, reflects on a career in life sciences leading to her win of the BIA Lifetime Achievement…

    Read more

  • News releases

    LifeArc launches Technology Transfer Fellowships

    LifeArc is delighted to launch a new Technology Transfer Fellowship programme in partnership with Imperial Innovations, Queen Mary Innovation and…

    Read more

  • News releases

    LifeArc study points towards expanded utility for antibody-drug candidates

    The study explores the potential for the use of antibody-drug conjugates (ADCs) in extracellular, inhibitory applications.

    Read more

  • News releases

    GOSH Charity and LifeArc launch £1M grant scheme

    Great Ormond Street Hospital Children’s Charity (GOSH Charity) and LifeArc, a leading UK medical research charity, today announce the launch…

    Read more

  • Blogs

    LifeArc AUTM Fellows programme – a look at 2018’s alumni

    Here we look back at the experiences of last years’ alumni and hope to provide insight into the programme for…

    Read more

  • News releases

    LifeArc and C4X Discovery join forces to develop small molecule drug candidates

    LifeArc and C4X Discovery join forces to develop small molecule drug candidates active against a high value, novel oncology and…

    Read more